相关临床试验
2
0 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
1948
已完成
2
100.0%
暂无批准数据
- The University at Buffalo received $5 million from the State University of New York to lead a statewide, multi-campus research network on age-related brain disorders. - The award is part of $10 million in New York State funding supporting the SUNY Brain Institute, with UB designated anchoring hub for its inaugural module. - UB will serve as hub for three years, coordinating shared-access, governance, data-integration and operational infrastructure across five SUNY institutions. - The network aims to accelerate development of new biomarkers, therapeutic targets and approaches to diagnosis, treatment and prevention of neurological disease.
- A genetically engineered, blight-tolerant American chestnut has received the first of several required approvals from U.S. federal regulatory agencies, a milestone toward distributing trees for restoration. - The tree carries a single wheat-derived gene that helps it tolerate chestnut blight by reducing damage rather than repelling the fungus. - Researchers hope to begin distributing trees within a few years, though landscape-scale restoration is expected to take decades. - The project offers a model for applying biotechnology to conservation of other threatened native tree species.
